Human Papillomavirus (HPV)
Cervarix Vaccine Protects Women against HPV that Causes Anal Cancer
- Details
- Category: Human Papillomavirus (HPV)
- Published on Tuesday, 30 August 2011 00:00
- Written by Liz Highleyman
The Cervarix human papillomavirus (HPV) vaccine reduced anal infection with cancer-causing HPV types 16 and 18 in a study of women in Costa Rica, according to a report in the September 2011 issue of The Lancet Oncology.
HPV Vaccine Reduces Cervical Abnormalities
- Details
- Category: Anal & Cervical Cancer
- Published on Tuesday, 05 July 2011 12:32
- Written by Liz Highleyman
Vaccination of young women in Australia against human papillomavirus (HPV) lowered incidence of serious cervical cell abnormalities and early cervical cancer by nearly 40%.
Researchers Develop HPV Protein Inhibitor
- Details
- Category: Human Papillomavirus (HPV)
- Published on Tuesday, 03 May 2011 05:40
- Written by Tufts
Researchers constructed a recombinant protein that interferes with the human papillomavirus (HPV) E2 protein, inhibiting viral replication and its ability to cause cancer.
Lopinavir Fights HPV in Cervical Cancer Cells
- Details
- Category: Human Papillomavirus (HPV)
- Published on Thursday, 05 May 2011 18:26
- Written by University of Manchester
The HIV protease inhibitor lopinavir (the main drug in Kaletra) blocked viral proteasome activitation and selectively killed pre-cancerous cervical cells infected with human papillomavirus (HPV).
As reported in the May 3, 2011, advance online edition of Antiviral Therapy, Gavin Batman and Ian Hampson from the University of Manchester in the U.K. and colleagues tested lopinavir in HPV-infected SiHa cervical carcinoma cells in a laboratory study.
FDA Approves New Human Papillomavirus Test
- Details
- Category: Human Papillomavirus (HPV)
- Published on Friday, 29 April 2011 05:26
- Written by FDA
The FDA this week approved Roche's new human papillomavirus test, which identifies genotypes of cancer-causing HPV types 16 and 18, as well as detecting 12 other high-risk types.